Abstract:Globally, pharmaceuticals and personal care products (PPCPs) are detected in surface waters receiving wastewater, yet their presence in biota, remain largely understudied. To address this, we conducted a study that measured 46 PPCPs in spot water samples and fish caught up- and downstream from wastewater treatment plants (WWTPs) in Victoria, Australia. We sampled 15 sites located along four waterways following a 3-site design: WWTP-discharge('hotspot'), 'upstream'(∼2 km) and 'downstream'(∼2 km). Spot water and fish were also sampled at reference sites >100 km from WWTP discharge (n = 3). Additionally, spot water samples were taken from WWTP effluent outflows (n = 3). From each locality, we analysed 3-12 fish (n = 131 total). In waterways, passive samplers (POCIS; ∼28d, n = 19 PPCPs) were also deployed. Individual fish (axial muscle) and water were analysed with LC-MS-MS. We found that PPCP concentrations in environmental surface water ranged from<0.02-0.97 μg/L. In WWTP effluent, the range was <0.02-1.4 μg/L. Of the 46 PPCPs analysed, 12 were detected in spot water samples and five in fish. In water, the highest concentration detected was for antidepressant venlafaxine (3 μg/L). The most frequently detected PPCPs: venlafaxine (54.9%), metoprolol (41.2%), propranolol (29.4%), carbamazepine (29.4%), caffeine (17.6%) and sulfamethoxazole (17.6%). Out of 131 fish analysed, 35 fish had detectable levels of PPCPs in the muscle tissue. The highest muscle concentrations were: venlafaxine (150 μg/kg, redfin perch), and sertraline (100 μg/kg, eel). Bioaccumulation factors ranged from 104 to 341L/kg for venlafaxine in redfins, 21-1,260L/kg for carbamazepine in redfins and eels, and 367-3,333L/kg for sertraline in eels. Based on our human health risk calculations for venlafaxine, carbamazepine, sertraline, triclosan, and caffeine, consumption of fish does not pose a significant risk to human health. Despite this, most of the detected PPCPs in surface waters exceeded 10 ng/L trigger value, which has led to further investigations by EPA. Our study highlights the need for using multiple lines of evidence for estimating risks of PPCPs.

Trace analysis of 47 psychotropic medications in environmental samples by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS)

Simultaneous Determination of 13 Psychiatric Pharmaceuticals in Sewage by Automated Solid Phase Extraction and Liquid Chromatography-Mass Spectrometry

Detection, Occurrence and Fate of 22 Psychiatric Pharmaceuticals in Psychiatric Hospital and Municipal Wastewater Treatment Plants in Beijing, China

Antidepressants As Emerging Contaminants: Occurrence in Wastewater Treatment Plants and Surface Waters in Hangzhou, China.

Unravelling psychoactive substances and their metabolites and transformation products: High-Resolution Mass Spectrometry approaches for comprehensive target and suspect screening in wastewater

Rapid Determination of Pharmaceuticals from Multiple Therapeutic Classes in Wastewater by Solid-Phase Extraction and Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry

Environmental Pollution Monitoring via Capillary Zone Electrophoresis and UHPLC Simultaneous Quantification of Some Antipsychotic Drug Residues in Industrial Wastewater Effluents

A UPLC-MS/MS Assay for Simultaneous Determination of Two Antipsychotics and Two Antidepressants in Human Plasma and Its Application in Clinic.

[Simultaneous Determination of 18 Pharmaceuticals and Personal Care Products in Surface Water by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry].

Determination of 89 drugs and other micropollutants in unfiltered wastewater and freshwater by LC-MS/MS: an alternative sample preparation approach

Simultaneous Occurrence of Psychotropic Pharmaceuticals in Surface Water of the Megacity Shanghai and Implication for Their Ecotoxicological Risks

Determination of antidepressants in surface and waste water samples by capillary electrophoresis with electrospray ionization mass spectrometric detection after preconcentration using off-line solid-phase extraction

Determination of Pharmaceuticals from Various Therapeutic Classes in Dewatered Sludge by Pressurized Liquid Extraction and High Performance Liquid Chromatography and Tandem Mass Spectrometry (HPLC-MS/MS)

Evaluation of eight psychoactive drugs used in Chinese cities by wastewater-based epidemiology

Simultaneous Quantification Of 38 Psychotropic Drugs And Relevant Metabolites In Blood Using Lc-Ms-Ms

Magnetic solid-phase extraction coupled with UHPLC-MS/MS for four antidepressants and one metabolite in clinical plasma and urine samples

Efficient Multiresidue Determination Method for 168 Pharmaceuticals and Metabolites: Optimization and Application to Raw Wastewater, Wastewater Effluent, and Surface Water in Beijing, China.

Pharmaceuticals in biota: The impact of wastewater treatment plant effluents on fish in Australia

Combining poly (methacrylic acid-coethylene glycol dimethacrylate) monolith microextraction and octadecyl phosphonic acid-modified zirconia-coated CEC with field-enhanced sample injection for analysis of antidepressants in human plasma and urine

Developing and Validating a Fast and Accurate Method to Quantify 18 Antidepressants in Oral Fluid Samples Using SPE and LC-MS-MS

Direct Rapid Analysis of Multiple PPCPs in Municipal Wastewater Using Ultrahigh Performance Liquid Chromatography–tandem Mass Spectrometry Without SPE Pre-Concentration